1
|
Sun T, Meerbrey KL, Kessler J, Botero M, Migliaccio I, Nguyen DX, Pavlova NN, Bernardi RJ, Schmitt E, Hilsenbeck SG, Creighton CJ, Shaw CA, Gibbs R, Wheeler D, Osborne CK, Schiff R, Elledge SJ, Westbrook TF. Abstract S6-10: Identification of a Novel Tumor Suppressor Network Reveals a Role for Proto-Oncogenic Receptor Tyrosine Kinases in Triple-Negative Breast Cancer. Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-s6-10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Breast cancer is a collection of diseases with distinct clinical behaviors and underlying genetic causes. Triple-negative breast cancer (TNBC) is a common subtype of breast cancer that confers a particularly poor prognosis and is refractory to current targeted therapies. Unfortunately, the molecular determinants driving this aggressive malignancy are poorly understood. Using an unbiased genetic screen, we have identified a novel tumor suppressor network that governs proliferation and transformation of TNBCs in vitro and in vivo. We define SECT21 as a core component in this network and a commonly inactivated tumor suppressor in TNBC. SECT21 is a potent suppressor of human mammary epithelial cell proliferation and transformation. SECT21 function is frequently compromised in human TNBCs by inactivating mutations, deletion, or loss of protein expression. Mechanistically, SECT21 is a tyrosine phosphatase that suppresses cellular transformation by interacting with and inhibiting several oncogenic receptor tyrosine kinases including HER2, EGFR, and PDGFR. Notably, the tumorigenic and metastatic potential of SECT21-deficient TNBCs is severely impaired by restoring SECT21 function or by inhibiting kinase targets of SECT21, suggesting that TNBCs are dependent on the proto-oncogenic tyrosine kinases constrained by SECT21. Collectively, these data identify SECT21 as a commonly inactivated tumor suppressor and provide a rationale for combinatorially targeting tyrosine kinases in TNBC and other cancers based on their profile of tyrosine phosphatase activity.
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr S6-10.
Collapse
Affiliation(s)
- T Sun
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - KL Meerbrey
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - J Kessler
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - M Botero
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - I Migliaccio
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - DX Nguyen
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - NN Pavlova
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - RJ Bernardi
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - E Schmitt
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - SG Hilsenbeck
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - CJ Creighton
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - CA Shaw
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - R Gibbs
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - D Wheeler
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - CK Osborne
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - R Schiff
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - SJ Elledge
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - TF. Westbrook
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| |
Collapse
|